An experimental “off-the-shelf” vaccine for recurring pancreatic and colorectal cancer is showing great promise so far. Early results show that the vaccine appears to be safe and is potentially prolonging people’s lives. Researchers at the University of California, Los Angeles, the Memorial Sloan Kettering Cancer Center in New York, and elsewhere...
Language
VN
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Arabic
